Can teleconsultations personalize kidney transplant Follow-Up?
NCT ID NCT01615900
First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time
Summary
Researchers are testing whether teleconsultations guided by a kidney transplant failure risk score can improve follow-up care for kidney transplant patients. The trial enrolls adults who received a deceased donor kidney transplant one year earlier and have internet access. Participants are randomly assigned to teleconsultation or standard in-person follow-up, and their care is tailored by a risk score that predicts early graft failure. The study measures serious adverse events, cost-effectiveness, and quality of life over two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Teleconsultation follow-up guided by a kidney transplant failure risk score
- What this could lead to
- If teleconsultations work, kidney transplant patients could receive more personalized follow-up that catches problems earlier and reduces hospital visits.
- What could go wrong
- This is a small, open-label study, so results may not apply to all transplant patients. Teleconsultation also depends on reliable internet and video equipment, which some patients may lack.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
155 people
The number who actually took part.
- Started
-
Feb 2012
- Finished
-
Jan 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patient * Having received a deceased donor renal transplant one year ago * Having an access internet high-speed * Having a compatible computer and supporting the videoconference * Calculable KTFS (Kidney Transplant Failure Score) * Patient having participated in a therapeutic educational program * Patient has given informed consent * Patient insured Exclusion Criteria: * Patient under age 18 * Patient having received a multi-organ transplant (heart kidney / liver kidney / kidney pancreas / lung kidney / heart lung kidney) * Patient non-compliant * BK virus nephropathy or BK positive viremia * CMV positive viremia * Identified and treated psychiatric disorders * Participation in another clinical study * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Renal transplant patient are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nantes University Hospital
Nantes, France